Peter Lamb, Ph.D.

Executive Vice President, Discovery Research and Chief Scientific Officer

Peter Lamb, Ph.D., has served as Executive Vice President, Discovery Research and Chief Scientific Officer since September 2009.  Dr. Lamb previously served in numerous other positions since joining Exelixis in October 2000, including as Senior Director, Molecular Pharmacology and Structural Biology from October 2000 until December 2003, Vice President, Discovery Pharmacology from December 2003 until January 2007 and Senior Vice President, Discovery Research and Chief Scientific Officer from January 2007 until August 2009.  From June 1992 until September 2000, Dr. Lamb held positions of increasing responsibility at Ligand Pharmaceuticals, most recently serving as Director of Transcription Research. Dr. Lamb has held post-doctoral research fellowships at the Carnegie Institution, Department of Embryology, with Dr. S.L. McKnight and the University of Oxford with Dr. N.J. Proudfoot, working in the field of gene regulation. Dr. Lamb has authored numerous articles in the fields of gene expression, signal transduction and oncology, and is an author on multiple issued and pending U.S. patents. Dr. Lamb has a Ph.D. in Molecular Biology from the ICRF/University of London and a B.A. in Biochemistry from the University of Cambridge.